MDxHealth
Medtech · Public
Molecular diagnostic tests using DNA methylation patterns to diagnose and predict outcomes in urologic cancers
mdxhealth.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $3.7M
- 51 awards · Veterans Affairs, Defense
- #146 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $2,051 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $85,997 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $24,606 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $11,153 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $21,717 | |
| Federal contract | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $20,505 | |
| Federal contract· 1 of 4 same day | Department of Defense · Medical-urology | $4,475 | |
| Federal contract· 2 of 4 same day | Department of Veterans Affairs · Igf::ct::igf Lab Software | $124,260 | |
| Federal contract· 3 of 4 same day | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $44,086 | |
| Federal contract· 4 of 4 same day | Department of Veterans Affairs · Igf::ot::igf - Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $6,152 | |
| Federal contract· 1 of 5 same day | Department of Defense · Medical-other | $2,859 | |
| Federal contract· 2 of 5 same day | Department of Veterans Affairs · Prostate Cancer Testing Po: 672C00067 | $59,054 | |
| Federal contract· 3 of 5 same day | Department of Veterans Affairs · Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $27,682 | |
| Federal contract· 4 of 5 same day | Department of Veterans Affairs · Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $12,183 | |
| Federal contract· 5 of 5 same day | Department of Veterans Affairs · Proprietary Genetic Testing In Support Of Patient Diagnosis, Ex. Cancer. | $3,691 | |
| Federal contract | Department of Veterans Affairs · Non-invasive Prostate Testing | $1,212 | |
| Federal contract | Department of Veterans Affairs · Ratification For Lab Service | $36,909 | |
| Federal contract· 1 of 2 same day | Department of Veterans Affairs · Mdx Health Genetic Prostate Cancer Testing Visn 19 | $24,340 | |
| Federal contract· 2 of 2 same day | Department of Veterans Affairs · Prostate Cancer Test: Pop: 10/01/2020 - 09/20/2021 | $136,651 | |
| Federal contract | Department of Veterans Affairs · Mdx Health Testing For Visn 19 | $28,151 | |
| Federal contract | Department of Veterans Affairs · Non Invasive Prostate Testing Option Year 2 | $404 | |
| Federal contract | Department of Veterans Affairs · Prostate Cancer Test | $221,662 | |
| Federal contract | Department of Veterans Affairs · Mdx Health Testing For Visn 19 | $90,117 | |
| Federal contract | Department of Veterans Affairs · Oncotype Prostate Testing | $204,348 | |
| Federal contract | Department of Veterans Affairs · Prostate Cancer Test | $144,666 | |
| Federal contract | Department of Veterans Affairs · Mdx Health Testing For Visn 19 | $114,920 | |
| Federal contract | Department of Veterans Affairs · Mdx Health Testing For Visn 19 | $43,972 | |
| Federal contract | Department of Veterans Affairs · Ama Oncotype Prostate Cancer Testing | $9,579 | |
| Federal contract | Department of Veterans Affairs · Oncotype Dx Prostate Testing | $213,926 | |
| Federal contract | Department of Veterans Affairs · Prostate Cancer Test- Option Two | $66,502 | |
| Federal contract | Department of Veterans Affairs · Mdx Health Testing For Visn 19 - Call Order For Option Year 4 | $132,826 | |
| Federal contract | Department of Veterans Affairs · Laboratory Services | $3,193 | |
| Federal contract | Department of Veterans Affairs · Oncotype Dx GPS Testing | $696,872 | |
| Federal contract | Department of Veterans Affairs · Oncotype Dx Genomic Prostate Testing Service For Big Spring Va | $3,232 | |
| Federal contract | Department of Veterans Affairs · Dx Prostate Testing | $3,193 | |
| Federal contract | Department of Veterans Affairs · Oncotype Dx Prostate Testing | $319,293 | |
| Federal contract | Department of Veterans Affairs · Prostate Cancer Test- Option Three | $85,939 | |
| Federal contract | Department of Veterans Affairs · Mdx Health Testing For Visn 19 | $243,669 | |
| Federal contract | Department of Veterans Affairs · Dx Prostate Testing | $27,658 | |
| Federal contract | Department of Veterans Affairs · Oncotype Dx Prostate Testing | $319,293 | |
| Federal contract | Department of Veterans Affairs · Mdxhealth GPS | $15,965 | |
| Federal contract | Department of Veterans Affairs · Do Prostate Cancer Test- Do Option 4 | $62,668 |
Federal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 143 | SWITCHBOX INC | $4.0M | — |
| 144 | Springactive, Inc. | $3.8M | — |
| 145 | Mattek Corporation | $3.8M | — |
| 146 | MDxHealth | $3.7M | — |
| 147 | Invitae Corp | $3.7M | $203M |
| 148 | ISENSE, LLC | $3.6M | — |
| 149 | BIOPAC SYSTEMS, INC. | $3.6M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.